Journalists can now register online for the 30th EORTC-NCI-AACR symposium on “Molecular Targets and Cancer Therapeutics”, which takes place in Dublin, Ireland, 13-16 November 2018.
The EORTC-NCI-AACR Symposium is unique in being THE scientific forum for developing cancer drugs for the future. Understanding the pathways and mechanisms that cause cancer and regulate the biological behaviour of tumour cells has led to the development of numerous new agents, ‘designer’ diagnostics, prognostic tests, ‘smart’ drugs, innovative targets for clinical trials and other entirely new ways of tackling cancer.
To bring these developments to patients as quickly and efficiently as possible requires international collaboration, early and optimal exchange of information, good quality translational research, efficient drug development and large prospective clinical trials.
At this Symposium, three of the world’s leading cancer organisations:
The European Organisation for Research and Treatment of Cancer (EORTC) The USA’s National Cancer Institute (NCI) The American Association for Cancer Research (AACR)
will join forces in Dublin on 13-16 November 2018 to provide a platform for presenting recent advances in pre-clinical and clinical research. Around 1,500 international experts in the field will be discussing innovations in drug development, target selection and the impact of new discoveries in molecular biology,
Article originally posted at